Form 8-K - Current report:
SEC Accession No. 0000899923-21-000049
Filing Date
2021-06-03
Accepted
2021-06-03 16:07:08
Documents
12
Period of Report
2021-06-03
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mygn-20210603.htm   iXBRL 8-K 46277
  Complete submission text file 0000899923-21-000049.txt   181978

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20210603.xsd EX-101.SCH 1896
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20210603_lab.xml EX-101.LAB 23970
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20210603_pre.xml EX-101.PRE 12634
5 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20210603_htm.xml XML 10756
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26642 | Film No.: 21992551
SIC: 2835 In Vitro & In Vivo Diagnostic Substances